Movement Alert｜INSILICO Rises 5.64% in Regular Trading, Strategic Partnership with MobiDrop to Co-Build AI-Ready Data Infrastructure

Market Focus

Sep 08

On September 8, INSILICO rose 5.64% in regular trading, trading at HK$51.45 per share, with turnover of HK$72.39 million.

On the news front, INSILICO announced on September 7 a strategic partnership with MobiDrop to co-build AI-Ready multi-omics data infrastructure. Under the agreement, MobiDrop's scaled multi-omics data will be systematically integrated into INSILICO's Pharma.AI platform data warehouse, providing training, validation, and model iteration support for its core generative biology platform PandaOmics and the newly released multi-agent-driven Virtual Aging Cell (VAC) platform.

Multiple recent catalysts have also supported sentiment. The company's chairman disclosed a plan to purchase up to HK$16 million in shares during September using personal funds, signaling confidence in the company's long-term value. Additionally, the company completed a $305 million zero-coupon convertible bond issuance on September 3, with net proceeds of approximately $301.6 million earmarked for clinical trials, R&D team expansion, and scientific foundation models. Citi maintained its Buy rating with an HK$85 target price, naming INSILICO its top sector pick.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1117938753"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1117938753\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1117938753?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-08 09:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117938753","market":"us","top_or_hot":-1,"title":"Movement Alert｜INSILICO Rises 5.64% in Regular Trading, Strategic Partnership with MobiDrop to Co-Build AI-Ready Data Infrastructure","media":"Market Focus","content":"<p><p>On September 8, INSILICO rose 5.64% in regular trading, trading at HK$51.45 per share, with turnover of HK$72.39 million.</p><p>On the news front, INSILICO announced on September 7 a strategic partnership with MobiDrop to co-build AI-Ready multi-omics data infrastructure. Under the agreement, MobiDrop's scaled multi-omics data will be systematically integrated into INSILICO's Pharma.AI platform data warehouse, providing training, validation, and model iteration support for its core generative biology platform PandaOmics and the newly released multi-agent-driven Virtual Aging Cell (VAC) platform.</p><p>Multiple recent catalysts have also supported sentiment. The company's chairman disclosed a plan to purchase up to HK$16 million in shares during September using personal funds, signaling confidence in the company's long-term value. Additionally, the company completed a $305 million zero-coupon convertible bond issuance on September 3, with net proceeds of approximately $301.6 million earmarked for clinical trials, R&D team expansion, and scientific foundation models. Citi maintained its Buy rating with an HK$85 target price, naming INSILICO its top sector pick.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜INSILICO Rises 5.64% in Regular Trading, Strategic Partnership with MobiDrop to Co-Build AI-Ready Data Infrastructure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜INSILICO Rises 5.64% in Regular Trading, Strategic Partnership with MobiDrop to Co-Build AI-Ready Data Infrastructure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-08 09:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 8, INSILICO rose 5.64% in regular trading, trading at HK$51.45 per share, with turnover of HK$72.39 million.</p><p>On the news front, INSILICO announced on September 7 a strategic partnership with MobiDrop to co-build AI-Ready multi-omics data infrastructure. Under the agreement, MobiDrop's scaled multi-omics data will be systematically integrated into INSILICO's Pharma.AI platform data warehouse, providing training, validation, and model iteration support for its core generative biology platform PandaOmics and the newly released multi-agent-driven Virtual Aging Cell (VAC) platform.</p><p>Multiple recent catalysts have also supported sentiment. The company's chairman disclosed a plan to purchase up to HK$16 million in shares during September using personal funds, signaling confidence in the company's long-term value. Additionally, the company completed a $305 million zero-coupon convertible bond issuance on September 3, with net proceeds of approximately $301.6 million earmarked for clinical trials, R&D team expansion, and scientific foundation models. Citi maintained its Buy rating with an HK$85 target price, naming INSILICO its top sector pick.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1117938753","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117938753","pubTimestamp":1788831139,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 8, INSILICO rose 5.64% in regular trading, trading at HK$51.45 per share, with turnover of HK$72.39 million.On the news front, INSILICO announced on September 7 a strategic partnership...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"动态警报|INSILICO 常规交易上涨 5.64%，与 MobiDrop 建立战略合作伙伴关系，共同构建人工智能就绪的数据基础设施","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On September 8, INSILICO rose 5.64% in regular trading, trading at HK$51.45 per share, with turnover of HK$72.39 million.On the news front, INSILICO announced on September 7 a strategic partnership with MobiDrop to co-build AI-Ready multi-omics data infrastructure. Under the agreement, MobiDrop's scaled multi-omics data will be systematically integrated into INSILICO's Pharma.AI platform data warehouse, providing training, validation, and model iteration support for its core generative biology platform PandaOmics and the newly released multi-agent-driven Virtual Aging Cell (VAC) platform.Multiple recent catalysts have also supported sentiment. The company's chairman disclosed a plan to purchase up to HK$16 million in shares during September using personal funds, signaling confidence in the company's long-term value. Additionally, the company completed a $305 million zero-coupon convertible bond issuance on September 3, with net proceeds of approximately $301.6 million earmarked for clinical trials, R&D team expansion, and scientific foundation models. Citi maintained its Buy rating with an HK$85 target price, naming INSILICO its top sector pick.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}